首页> 外文期刊>Parasitology Research >Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.
【24h】

Comparative evaluation of immunization with recombinant protein and plasmid DNA vaccines of fusion antigen ROP2 and SAG1 from Toxoplasma gondii in mice: cellular and humoral immune responses.

机译:弓形虫融合抗原ROP2和SAG1的重组蛋白和质粒DNA疫苗免疫小鼠的比较评估:细胞和体液免疫反应。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this work was to evaluate immune responses in BALB/c mice vaccinated subcutaneously by recombinant protein, or intramuscularly by plasmid DNA with fusion antigen of rhoptry protein 2 (ROP2) and major surface protein 1 (SAG1) from Toxoplasma gondii (T. gondii). BALB/c mice were immunized with one of three different antigen formulations respectively, which were rROP2-SAG1, pcROP2-SAG1, and pcROP2-SAG1 boosted with rROP2-SAG1. The production of IgG, IgG subclasses, lymphoproliferation, and level of gamma interferon (IFN-gamma) were detected after vaccination. The animals vaccinated with rROP2-SAG1 quickly developed specific anti-TLA (T. gondii lysate antigen) antibodies, which continued to rise after immunization. However, production of IgG against TLA in mice vaccinated with pcROP2-SAG1 was relatively slow and maintained a high level after reaching plateau. There are more vigorous specific lymphoproliferative responses observed in mice of group rROP2-SAG1 than in pcROP2-SAG1. Immune responses in mice of group pcROP2-SAG1 boosted with rROP2-SAG1 were similar to the protein immunization group. Three immunization procedures resulted in a similar level of IFN-gamma production. Our results indicate that BALB/c mice vaccinated by three immunization procedures induce similar humoral and cellular immunity against infection of T. gondii. Mice immunized with recombinant protein rROP2-SAG1 produce more humoral immune responses than mice immunized with other antigen formulations.
机译:这项工作的目的是评估皮下注射重组BALB / c小鼠的免疫反应,或用质粒DNA肌肉注射带有弓形体弓形虫(R.optry蛋白2(ROP2)和主要表面蛋白1(SAG1)的融合抗原的质粒DNA)免疫。刚地)。用三种不同的抗原制剂之一分别对BALB / c小鼠进行免疫,这三种抗原制剂分别是rROP2-SAG1,pcROP2-SAG1和rROP2-SAG1增强的pcROP2-SAG1。疫苗接种后检测出IgG的产生,IgG亚类,淋巴增殖和γ干扰素(IFN-γ)水平。接种了rROP2-SAG1的动物迅速产生了特异性的抗TLA(刚地弓形虫溶胞产物抗原)抗体,免疫后这种抗体持续升高。但是,在接种pcROP2-SAG1的小鼠中,针对TLA的IgG的产生相对缓慢,并且在达到平稳期后仍保持高水平。在rROP2-SAG1组的小鼠中观察到比pcROP2-SAG1更强烈的特异性淋巴增生反应。用rROP2-SAG1增强的pcROP2-SAG1组小鼠的免疫应答与蛋白质免疫组相似。三种免疫程序导致相似水平的IFN-γ产生。我们的结果表明,通过三种免疫程序接种的BALB / c小鼠诱导了类似的针对弓形虫感染的体液和细胞免疫。用重组蛋白rROP2-SAG1免疫的小鼠比用其他抗原制剂免疫的小鼠产生更多的体液免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号